J G Garweg

Summary

Publications

  1. doi request reprint Therapy for ocular toxoplasmosis--the future
    Justus G Garweg
    Swiss Eye Institute, University of Bern, Bern Switzerland
    Ocul Immunol Inflamm 21:300-5. 2013
  2. doi request reprint Pathophysiology of proliferative vitreoretinopathy in retinal detachment
    Justus G Garweg
    Swiss Eye Institute and University of Bern, Bern, Switzerland
    Surv Ophthalmol 58:321-9. 2013
  3. ncbi request reprint Immunopathology in ocular toxoplasmosis: facts and clues
    Justus G Garweg
    Clinic for Vitreoretinal Disease and Uveitis, Swiss Eye Institute, Bern, Switzerland
    Mem Inst Oswaldo Cruz 104:211-20. 2009
  4. doi request reprint Outcome indicators for vitrectomy in Terson syndrome
    Justus G Garweg
    Swiss Eye Institute, Bern, Switzerland
    Acta Ophthalmol 87:222-6. 2009
  5. doi request reprint Secondary intraocular lenses in eyes with aphakia or dislocated IOL: impact of suture fixation on early and late complications
    J G Garweg
    Swiss Eye Institute, Clinic for Vitreoretinal Disease, Bern, Switzerland
    Klin Monbl Augenheilkd 225:338-41. 2008
  6. doi request reprint Recurrence characteristics in European patients with ocular toxoplasmosis
    J G Garweg
    Swiss Eye Institute, Clinic for Vitreoretinal Disease, Bern, Switzerland
    Br J Ophthalmol 92:1253-6. 2008
  7. ncbi request reprint Recovery of visual field and acuity after removal of epiretinal and inner limiting membranes
    J G Garweg
    Clinic for Vitreoretinal Disease, Swiss Eye Institute, Bremgartenstr 119, CH 3012 Bern, Switzerland
    Br J Ophthalmol 92:220-4. 2008
  8. ncbi request reprint [Update on vitrectomy for pediatric uveitis]
    J G Garweg
    Swiss Eye Institute, Bern, Schweiz
    Klin Monbl Augenheilkd 224:538-42. 2007
  9. pmc Diagnostic approach to ocular toxoplasmosis
    Justus G Garweg
    Swiss Eye Institute and University of Bern, Bern, Switzerland
    Ocul Immunol Inflamm 19:255-61. 2011
  10. doi request reprint Anti-retinal autoantibodies in experimental ocular and systemic toxoplasmosis
    Justus G Garweg
    Swiss Eye Institute, Bremgartenstrasse 119, CH 3012, Bern, Switzerland
    Graefes Arch Clin Exp Ophthalmol 248:573-84. 2010

Detail Information

Publications24

  1. doi request reprint Therapy for ocular toxoplasmosis--the future
    Justus G Garweg
    Swiss Eye Institute, University of Bern, Bern Switzerland
    Ocul Immunol Inflamm 21:300-5. 2013
    ..Treatment of ocular toxoplasmosis is aimed at stabilizing visual function and reducing recurrence rates...
  2. doi request reprint Pathophysiology of proliferative vitreoretinopathy in retinal detachment
    Justus G Garweg
    Swiss Eye Institute and University of Bern, Bern, Switzerland
    Surv Ophthalmol 58:321-9. 2013
    ....
  3. ncbi request reprint Immunopathology in ocular toxoplasmosis: facts and clues
    Justus G Garweg
    Clinic for Vitreoretinal Disease and Uveitis, Swiss Eye Institute, Bern, Switzerland
    Mem Inst Oswaldo Cruz 104:211-20. 2009
    ..Its characteristic and variable features have been identified and the potential relevance of autoimmunity has been assessed. In light of this knowledge, potential future treatment options have been considered...
  4. doi request reprint Outcome indicators for vitrectomy in Terson syndrome
    Justus G Garweg
    Swiss Eye Institute, Bern, Switzerland
    Acta Ophthalmol 87:222-6. 2009
    ..Therefore, we reviewed our cases in order to assess factors interfering with the functional outcome and complication rates after vitrectomy...
  5. doi request reprint Secondary intraocular lenses in eyes with aphakia or dislocated IOL: impact of suture fixation on early and late complications
    J G Garweg
    Swiss Eye Institute, Clinic for Vitreoretinal Disease, Bern, Switzerland
    Klin Monbl Augenheilkd 225:338-41. 2008
    ..The present analysis compares the outcomes and complications experienced in our own series of patients...
  6. doi request reprint Recurrence characteristics in European patients with ocular toxoplasmosis
    J G Garweg
    Swiss Eye Institute, Clinic for Vitreoretinal Disease, Bern, Switzerland
    Br J Ophthalmol 92:1253-6. 2008
    ..Sixty-three patients completed the questionnaire and were included in the study. They were allocated according to their median age to one of two groups (group 1: <20.9 years; group 2: >or=20.9 years)...
  7. ncbi request reprint Recovery of visual field and acuity after removal of epiretinal and inner limiting membranes
    J G Garweg
    Clinic for Vitreoretinal Disease, Swiss Eye Institute, Bremgartenstr 119, CH 3012 Bern, Switzerland
    Br J Ophthalmol 92:220-4. 2008
    ..Preoperatively, and 1, 6 and 12 months postoperatively, distance and reading visual acuities were evaluated; the central visual field was assessed by automated static perimetry...
  8. ncbi request reprint [Update on vitrectomy for pediatric uveitis]
    J G Garweg
    Swiss Eye Institute, Bern, Schweiz
    Klin Monbl Augenheilkd 224:538-42. 2007
    ..Addressing this question has been reinforced since the recent introduction of the new and relatively well tolerated medical treatment options using biologicals, i. e. TNFalpha blocking agents...
  9. pmc Diagnostic approach to ocular toxoplasmosis
    Justus G Garweg
    Swiss Eye Institute and University of Bern, Bern, Switzerland
    Ocul Immunol Inflamm 19:255-61. 2011
    ..Herein, the authors attempt to provide a simple and practicable algorithm for a clinically tailored diagnostic approach in atypical instances...
  10. doi request reprint Anti-retinal autoantibodies in experimental ocular and systemic toxoplasmosis
    Justus G Garweg
    Swiss Eye Institute, Bremgartenstrasse 119, CH 3012, Bern, Switzerland
    Graefes Arch Clin Exp Ophthalmol 248:573-84. 2010
    ..By establishing an experimental rabbit model of systemic and of primary and secondary ocular toxoplasmosis, we wished to investigate the onset and development of humoral response to retinal S-antigen...
  11. ncbi request reprint PVR recurrence and the timing of silicon oil removal
    M Halberstadt
    Department of Ophthalmology, University of Bern, Inselspital, Bern, Switzerland
    Klin Monbl Augenheilkd 223:361-6. 2006
    ..We wanted to ascertain whether the anatomical and functional outcomes of surgery in patients with a reattached retina and recurrent PVR can be improved by delaying the removal of SO...
  12. pmc Early aqueous humor analysis in patients with human ocular toxoplasmosis
    J G Garweg
    Department of Ophthalmology, University of Bern, Inselspital, CH 3010 Bern, Switzerland
    J Clin Microbiol 38:996-1001. 2000
    ..However, T. gondii-specific IgA was found within the aqueous humors of 11 of 43 patients (26%); measurement of the T. gondii-specific IgA level thus contributed substantially to the diagnostic sensitivity of the laboratory tests...
  13. ncbi request reprint The diagnostic yield of vitrectomy specimen analysis in chronic idiopathic endogenous uveitis
    J G Garweg
    Swiss Eye Institute, Gossetstrasse 43, CH 3084 Wabern, Switzerland
    Eur J Ophthalmol 16:588-94. 2006
    ..In an attempt to evaluate the impact of recently acquired analytic methods, the authors assessed the current diagnostic yield in CIU...
  14. ncbi request reprint [Congenital ocular toxoplasmosis--ocular manifestations and prognosis after early diagnosis of infection]
    J G Garweg
    Universitats Augenklinik, Inselspital, Bern, Schweiz
    Klin Monbl Augenheilkd 222:721-7. 2005
    ..The aim of the present review is to report about the long-term outcome of functional and morphological manifestations after an early confirmation of the diagnosis...
  15. ncbi request reprint Primary retinal reattachment surgery: anatomical and functional outcome in phakic and pseudophakic eyes
    M Halberstadt
    Department of Ophthalmology, University of Bern, Inselspital Bern, Switzerland
    Eye (Lond) 19:891-8. 2005
    ....
  16. ncbi request reprint Toxic effects of indocyanine green, infracyanine green, and trypan blue on the human retinal pigmented epithelium
    L Kodjikian
    Department of Ophthalmology, Inselspital, University of Bern, 3010 Bern, Switzerland
    Graefes Arch Clin Exp Ophthalmol 243:917-25. 2005
    ..We therefore compared the acute and chronic toxicities of these stains on cultured human retinal pigmented epithelial (RPE) cells using clinically relevant concentrations and an identical experimental setup for each agent...
  17. ncbi request reprint Vitrectomy for juvenile uveitis: prognostic factors for the long-term functional outcome
    P Trittibach
    Division for Vitreoretinal Diseases, Department of Ophthalmology, Inselspital, University of Bern, Bern, Switzerland
    Eye (Lond) 20:184-90. 2006
    ..Further, predictive preoperative factors associated with a beneficial visual outcome were assessed...
  18. doi request reprint [Diabetic maculopathy and retinopathy. Functional and sociomedical significance]
    J G Garweg
    Swiss Eye Institute, Berner Augenklinik am Lindenhofspital, Universitat Bern, Bremgartenstrasse 119, 3012, Bern, Switzerland
    Ophthalmologe 107:628-35. 2010
    ..Diabetic macular edema (DME) is already a leading cause of blindness in the working-age population in developed countries, and its impact is expected to increase dramatically...
  19. ncbi request reprint Determinants of immunodiagnostic success in human ocular toxoplasmosis
    J G Garweg
    Department of Ophthalmology, University of Bern, Inselspital, 3010 Bern, Switzerland
    Parasite Immunol 27:61-8. 2005
    ..Against this background, current diagnostic strategies need to be re-evaluated with a view to future improvements...
  20. ncbi request reprint [Options and strategy for the treatment of chronic endogenous uveitis]
    J G Garweg
    Swiss Eye Institute, Augenklinik am Lindenhofspital, Bern, Schweiz
    Klin Monbl Augenheilkd 224:367-72. 2007
    ....
  21. ncbi request reprint Topical rivastigmine, a selective acetylcholinesterase inhibitor, lowers intraocular pressure in rabbits
    D Goldblum
    Department of Ophthalmology, University of Bern, Inselspital, Switzerland
    J Ocul Pharmacol Ther 16:29-35. 2000
    ..No conjunctival discharge or other signs of drug related local toxicity were found. Rivastigmine, a selective antagonist of AChE, lowers IOP significantly and may thus be of potential use in glaucoma therapy...
  22. pmc The outcome of corneal grafting in patients with stromal keratitis of herpetic and non-herpetic origin
    M Halberstadt
    Department of Ophthalmolgy, University of Bern, Inselspital, CH 3010 Bern, Switzerland
    Br J Ophthalmol 86:646-52. 2002
    ..To evaluate the outcome of corneal grafting in patients with stromal keratitis of herpetic (HSK) and non-herpetic origin, using predefined diagnostic criteria and standardised postoperative therapeutic strategies...
  23. ncbi request reprint Influence of intraocular lens material on the development of acute endophthalmitis after cataract surgery?
    L Kodjikian
    Department of Ophthalmology, Croix Rousse Hospital, University of Lyon I Claude Bernard, Lyon, France
    Eye (Lond) 22:184-93. 2008
    ..To investigate the causal relationship between acute postoperative endophthalmitis (POE) after cataract surgery and the biomaterial properties of the intraocular lens (IOLs) implanted...
  24. ncbi request reprint [Ocular toxoplasmosis and toxocariasis in childhood]
    C M E Deuter
    Universitatsklinikum Tubingen, Department für Augenheilkunde, Universitats Augenklinik, Tubingen
    Klin Monbl Augenheilkd 224:483-7. 2007
    ..With this survey we, therefore, wish to provide a current, practice-oriented overview on the infection, ocular manifestations, diagnosis and treatment of ocular toxoplasmosis and toxocariasis in childhood...